In the context of leukemia, LMP-induced cell death could be integrated into existing treatment strategies by using agents that promote lysosomal destabilization, thereby sensitizing leukemia cells to chemotherapy or other therapies. The gene discussed is PDLIM7; the disease is leukemia.